Inventor · name-matched record
VAN BLARCOM THOMAS JOHN
3 granted patents·1 pending application·0 citations·filing 2020–2025
41Inventor score
Technology areasA61K
Files withALLOGENE THERAPEUTICS INC4
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
4 records- 0171US2026042857A1Selective targeting of host cd70+ alloreactive cells to prolong allogeneic car t cell persistenceALLOGENE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0262US12577290B2FasL expression and FasR gene knockout to protect therapeutic cells from allogeneic rejection and activation-induced cell deathALLOGENE THERAPEUTICS INC·Filed 2022·Granted Mar 17, 2026·0 cites·22 claims
- 0359US12577283B2Knockdown or knockout of one or more of TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK to mitigate t cell recognition of allogeneic cell productsALLOGENE THERAPEUTICS INC·Filed 2022·Granted Mar 17, 2026·0 cites·39 claims
- 0448US12528856B2Chimeric cytokine receptors comprising TGF β binding domainsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Jan 20, 2026·0 cites·40 claims
Join the waitlist — get patent alerts
Get an alert when VAN BLARCOM THOMAS JOHN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →